BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Metronidazole

A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.

300+ PubMed studies analyzed · 26 RCTs · Evidence Score: 47.3

Research Domains

Metronidazole has been studied across 13 research domains including ⏳ Longevity & Aging, 🧠 Focus & Attention, 🫁 Liver & Detox, 🦠 Gut & Microbiome, 🔬 Oncology. The primary research focus is ⏳ Longevity & Aging with 6% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Metronidazole, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ns398
3 shared targets
Tobramycin
2 shared targets
Camphor
2 shared targets
Tigecycline
2 shared targets
Oseltamivir
2 shared targets
Levamisole
2 shared targets
Oxcarbazepine
3 shared targets
Lamivudine
2 shared targets
Valsartan
2 shared targets
Lidocaine
2 shared targets
Loading evidence profile...

This evidence profile for Metronidazole is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.